Mydicar
Mydicar
Mydicar (pronounced: my-dih-car) is a genetically targeted enzyme replacement therapy intended to restore levels of an enzyme that helps regulate stress in the heart.
Etymology
The term "Mydicar" is a brand name and does not have a known etymology.
Definition
Mydicar is a bioengineered version of the human enzyme serine threonine kinase, which is known to play a crucial role in the regulation of the heart's response to stress. It is designed to restore the enzyme's levels in patients with heart failure, thereby improving the heart's ability to pump blood.
Usage
Mydicar is used in the treatment of heart failure, a condition in which the heart can't pump enough blood to meet the body's needs. It is administered directly into the coronary arteries during a cardiac catheterization procedure.
Related Terms
- Heart Failure: A chronic condition in which the heart doesn't pump blood as well as it should.
- Serine Threonine Kinase: An enzyme that plays a crucial role in the regulation of the heart's response to stress.
- Cardiac Catheterization: A procedure used to diagnose and treat certain cardiovascular conditions, including heart failure.
See Also
- Gene Therapy: The therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease.
- Enzyme Replacement Therapy: A medical treatment which replaces an enzyme that is deficient or absent in the body.
External links
- Medical encyclopedia article on Mydicar
- Wikipedia's article - Mydicar
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski